» Articles » PMID: 18563842

Accuracy and Reproducibility of Transient Elastography for the Diagnosis of Fibrosis in Pediatric Nonalcoholic Steatohepatitis

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2008 Jun 20
PMID 18563842
Citations 126
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Transient elastography (TE) has received increasing attention as a means to evaluate disease progression in chronic liver disease patients. In this study, we assessed the value of TE for the prediction of fibrosis stage in a cohort of pediatric patients with nonalcoholic steatohepatitis. Furthermore, TE interobserver agreement was evaluated. TE was performed in 52 consecutive biopsy-proven nonalcoholic steatohepatitis patients (32 males, 20 females, age 13.6 +/- 2.44 years). The area under the receiver operating characteristic curves for the prediction of "any" (>or=1), significant (>or=2), or advanced fibrosis (>or=3) were 0.977, 0.992, and 1, respectively. Calculation of multilevel likelihood ratios showed that TE values <5, <7, and <9 kPa, suggest the presence of "any" fibrosis, significant fibrosis, and advanced fibrosis, respectively. TE values between 5 and 7 kPa predict a fibrosis stage of 1, but with some degree of uncertainty. TE values between 7 and 9 kPa predict fibrosis stages 1 or 2, but cannot discriminate between these two stages. TE values of at least 9 kPa are associated with the presence of advanced fibrosis. The intraclass correlation coefficient for absolute agreement was 0.961.

Conclusion: TE is an accurate and reproducible methodology to identify pediatric subjects without fibrosis or significant fibrosis, or with advanced fibrosis. In patients in which likelihood ratios are not optimal to provide a reliable indication of the disease stage, liver biopsy should be considered when clinically indicated.

Citing Articles

Evaluating Pediatric NAFLD with Controlled Attenuation Parameter: A Comprehensive Narrative Review.

Arteaga I, Chacon C, Martinez-Escude A, Rojano I, Diez-Fadrique G, Carmona-Cervello M Diagnostics (Basel). 2025; 15(3).

PMID: 39941229 PMC: 11816681. DOI: 10.3390/diagnostics15030299.


Prediction of hepatic fibrosis using the aspartate transaminase-to-platelet ratio index in children and adolescents with metabolic dysfunction-associated steatotic liver disease.

Jin H, Noh E, Jeong H, Hwang I BMC Pediatr. 2024; 24(1):788.

PMID: 39614232 PMC: 11607948. DOI: 10.1186/s12887-024-05263-3.


Pediatric MASLD: current understanding and practical approach.

Stroes A, Vos M, Benninga M, Koot B Eur J Pediatr. 2024; 184(1):29.

PMID: 39560782 DOI: 10.1007/s00431-024-05848-1.


Elastography as a non-invasive method of screening non-alcoholic fatty liver disease in the adult phenotype of paediatric obstructive sleep apnoea.

Durdikova A, Durdik P, Prso M, Dvorska D, Remen L, Vojtkova J Sleep Breath. 2024; 28(6):2653-2661.

PMID: 39264533 PMC: 11567998. DOI: 10.1007/s11325-024-03149-3.


KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease.

Kim M, Han J, An J, Kim B, Jin Y, Kim S Clin Mol Hepatol. 2024; 30(Suppl):S5-S105.

PMID: 39159947 PMC: 11493350. DOI: 10.3350/cmh.2024.0506.